Potential Treatment Modalities for Glaucomatous Neuropathy: Neuroprotection and Neuroregeneration

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of glaucoma

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00061198-199612000-00012PMID 8946301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HU-211, a Nonpsychotropic Cannabinoid, Produces Short- and Long-Term Neuroprotection after Optic Nerve Axotomy

  1996cited by this paper
• Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.

  1995cited by this paper
• Clinical experience with excitatory amino acid antagonist drugs.

  1995cited by this paper
• Programmed cell death of retinal ganglion cells during experimental glaucoma.

  1995cited by this paper
• Primary open-angle glaucoma is not associated with photoreceptor loss.

  1995cited by this paper
• Mechanisms of optic nerve damage in primary open angle glaucoma.

  1994cited by this paper
• Glutamate receptor antagonists protect against ischemia-induced retinal damage.

  1994cited by this paper
• Apoptosis in adult retinal ganglion cells after axotomy.

  1994cited by this paper
• Prophylactic Neuroprotection for Cerebral Ischemia

  1994cited by this paper
• Recovery of visual response of injured adult rat optic nerves treated with transglutaminase.

  1994cited by this paper
• Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death.

  1994cited by this paper
• Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.

  1994cited by this paper
• The nerve of glaucoma!

  1994cited by this paper
• Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival.

  1994cited by this paper
• Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma.

  1994cited by this paper
• Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported.

  1994cited by this paper
• Molecular mechanisms of trauma-induced neuronal degeneration.

  1993cited by this paper
• Basic and Clinical Studies of Pharmacologic Effects on Recovery from Brain Injury

  1993cited by this paper
• Conceptual and Practical Issues in the Pharmacological Treatment of Brain Injury

  1993cited by this paper
• Experimental neurobiology of central nervous system trauma.

  1993cited by this paper
• bcl-2 inhibits death of central neural cells induced by multiple agents.

  1993cited by this paper
• Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats.

  1993cited by this paper
• Flunarizine enhances rat retinal ganglion cell survival after axotomy.

  1993cited by this paper
• Calcium channel blockers in the management of low-tension and open-angle glaucoma.

  1993cited by this paper
• Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy.

  1993cited by this paper
• Basic mechanisms of traumatic brain damage.

  1993cited by this paper
• Mechanisms of drug actions against neuronal damage caused by ischemia--an overview.

  1993cited by this paper
• Protective effects of flunarizine on ischemic injury in the rat retina.

  1992cited by this paper
• GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.

  1992cited by this paper
• Regeneration of lesioned CNS axons by neutralization of neurite growth inhibitors: a short review.

  1992cited by this paper
• Pharmacological strategies in CNS trauma.

  1992cited by this paper
• Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

  1991cited by this paper
• Visual field global indices in patients with reversal of glaucomatous cupping after intraocular pressure reduction.

  1991cited by this paper
• GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve.

  1991cited by this paper
• Treatment of traumatic optic neuropathy with corticosteroids.

  1990cited by this paper
• Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome

  1990cited by this paper
• Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.

  1989cited by this paper
• Correlation of visual function with optic nerve and nerve fiber layer structure in glaucoma.

  1989cited by this paper
• Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats

  1988cited by this paper
• Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat

  1987cited by this paper
• The use of peripheral nerve grafts to enhance neuronal survival, promote growth and permit terminal reconnections in the central nervous system of adult rats.

  1987cited by this paper
• Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.

  1981cited by this paper
• Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport.

  1980cited by this paper
• Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping.

  1978cited by this paper
• Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey.

  1977cited by this paper
• The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve.

  1976cited by this paper
• Pathology of the optic nerve in experimental acute glaucoma. Electron microscopic studies.

  1968cited by this paper

• Potential role of Lycium barbarum polysaccharides in glaucoma management: evidence from preclinical in vivo studies

  2023cites this paper
• An Optimized Animal Model of Lysolecithin Induced Demyelination in Optic Nerve; More Feasible, More Reproducible, Promising for Studying the Progressive forms of Multiple Sclerosis.

  2021cites this paper
• [Structural endpoints for glaucoma studies].

  2019cites this paper
• The neuroprotective role of citicoline treatment in glaucoma – 6 months results of a prospective therapeutic trial

  2019cites this paper
• Amacrine cells coupled to ganglion cells via gap junctions are highly vulnerable in glaucomatous mouse retinas

  2019cites this paper
• Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review

  2018cites this paper
• Strukturelle Endpunkte für Glaukomstudien

  2018cites this paper
• Neuroprotection for treatment of glaucoma in adults.

  2017cites this paper
• Novel therapeutic targets in uveitis

  2017cites this paper
• Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma

  2016cites this paper
• The Impact of the Eye in Dementia: The Eye and its Role in Diagnosis and Follow‐up

  2016cites this paper
• MicroRNA target prediction in glaucoma.

  2015cites this paper
• Neuroinflammation in Glaucoma and Optic Nerve Damage.

  2015cites this paper
• Pharmacotherapy of Glaucoma

  2015cites this paper
• Glaucoma and Alzheimer's disease: Their clinical similarity and future therapeutic strategies for glaucoma

  2014cites this paper
• Caprioli and Garway-Heath A Critical Reevaluation of Current Glaucoma Management S 3

  2014cites this paper
• Visual improvement following glaucoma surgery: a case report

  2014cites this paper
• Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush

  2014cites this paper
• The retina as a window to the brain—from eye research to CNS disorders

  2013cites this paper
• Neuroprotection for treatment of glaucoma in adults (Review)

  2013cites this paper
• Involvement of P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in rats.

  2013cites this paper
• Neuroprotection for treatment of glaucoma in adults.

  2013cites this paper
• Neuroprotektive Ansätze

  2013cites this paper
• Pharmacological Neuroprotection for Glaucoma

  2012cites this paper
• Pharmacological Neuroprotection in Blinding Eye Diseases

  2012cites this paper
• Neuroprotection in Glaucoma: A Step Forward

  2012cites this paper
• Association of tumour necrosis factor‐alpha ‐308 G/A polymorphism with primary open‐angle glaucoma

  2012cites this paper
• Emerging Therapeutic Regimens for Glaucoma and Ocular Hypertension

  2011cites this paper
• Neuroprotection for treatment of glaucoma in adults.

  2010cites this paper
• Hyperbaric Oxygen Preconditioning Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush

  2010cites this paper
• Immunology and Glaucoma

  2010cites this paper
• Neuroprotective agents in glaucoma therapy: recent developments and future directions

  2010cites this paper
• Gene transcription profile of the detached retina (An AOS Thesis).

  2009cites this paper
• What's new in canine glaucoma?

  2009cites this paper
• Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.

  2008cites this paper
• Protective and Regenerative Autoimmunity in CNS Injury

  2008cites this paper
• 45 Protective and Regenerative Autoimmunity in CNS Injury

  2008cites this paper
• Wirkung und Nebenwirkungen von antiglaukomatösen Medikamenten – eine Übersicht

  2008cites this paper
• 45and Regenerative Autoimmunity in CNS Injury

  2008cites this paper
• Neuroprotection: A Valuable Goal in Glaucoma Management?

  2007cites this paper
• Modulating the immune system: a vaccine for glaucoma?

  2007cites this paper
• Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.

  2007cites this paper
• A critical reevaluation of current glaucoma management: International Glaucoma Think Tank, July 27-29, 2006, Taormina, Sicily.

  2007cites this paper
• Neuroprotection for prevention and treatment of glaucoma in adults

  2007cites this paper
• Model of acute injury to study neuroprotection.

  2007cites this paper
• Regeneration of retinal ganglion cell axons in organ culture is increased in rats with hereditary buphthalmos.

  2007cites this paper
• The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models.

  2006cites this paper
• T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure

  2005cites this paper
• Electroacupuncture Provides a New Approach to Neuroprotection in Rats with Induced Glaucoma

  2005cites this paper
• Retinal detachment neuropathology and potential strategies for neuroprotection.

  2005cites this paper
• Retinal Detachment Neuropathology and Potential Strategies for Neuroprotection

  2005cites this paper
• Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?

  2005cites this paper
• Optic nerve crush: protection and regeneration.

  2004cites this paper
• Neuroprotection in ophthalmology: a review.

  2004cites this paper
• Vaccination for glaucoma: dream or reality?

  2004cites this paper
• Therapeutic T-cell-based vaccination versus pharmacological intervention for neuroprotection: restoring lost homeostasis

  2004cites this paper
• Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.

  2004cites this paper
• Glutamate transporter localization does not correspond to the temporary functional recovery and late degeneration after acute ocular ischemia in rats.

  2004cites this paper
• Antioxidant intake and primary open-angle glaucoma: a prospective study.

  2003cites this paper
• Brinzolamide

  2003cites this paper
• Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.

  2003cites this paper
• Neuroprotection in glaucoma.

  2003cites this paper
• Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

  2003cites this paper
• Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.

  2002cites this paper
• Prospects for therapeutic vaccination with glatiramer acetate for neurodegenerative diseases such as Alzheimer's disease

  2002cites this paper
• Change in retinal nerve fiber layer thickness after laser in situ keratomileusis

  2002cites this paper
• Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy*

  2002cites this paper
• Discontinuation rates of topical glaucoma medications in a managed care population.

  2002cites this paper
• Current understanding of neuroprotection in glaucoma

  2002cites this paper
• [Use of memantine in progressive glaucoma. Case report].

  2002cites this paper
• Einsatz von Memantine bei Glaucoma fere absolutum

  2002cites this paper
• Pharmacodynamics of citicoline relevant to the treatment of glaucoma

  2002cites this paper
• Functional characterization of retina and optic nerve after acute and chronic elevation of the intraocular pressure in rats

  2002cites this paper
• Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.

  2002cites this paper
• Die Perspektive neuroprotektiver Glaukomtherapie

  2001cites this paper
• Vaccination for Neuroprotection in the Mouse Optic Nerve: Implications for Optic Neuropathies

  2001cites this paper
• Neuroprotection as a Treatment for Glaucoma: Pharmacological and Immunological Approaches

  2001cites this paper
• Harnessing the Immune System for Neuroprotection: Therapeutic Vaccines for Acute and Chronic Neurodegenerative Disorders

  2001cites this paper
• Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility.

  2001cites this paper
• [Prospects for neuroprotective glaucoma therapy].

  2001cites this paper
• Neuroprotection as a Treatment for Glaucoma: Pharmacological and Immunological Approaches

  2001cites this paper
• Relevance of the site of injury of glaucoma to neuroprotective strategies.

  2001cites this paper
• Physiological approaches to neuroprotection. boosting of protective autoimmunity.

  2001cites this paper
• Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines.

  2001cites this paper
• Autoimmunity can benefit self-maintenance.

  2000cites this paper
• IMPROVEMENT, NOT STABILIZATION OR SLOWING THE DECLINE OF OCULAR DISEASE: The Final Frontier in Treatment

  2000cites this paper
• Self-destructive and self-protective processes in the damaged optic nerve: implications for glaucoma.

  2000cites this paper
• Vaccination for T cell‐mediated neuroprotection: Dream or reality?

  2000cites this paper
• Molecular and Cellular Mechanisms of Spinal Cord Injury Therapies

  2000cites this paper
• Mitomycin-C in Glaucoma Filtering Surgery

  2000cites this paper
• T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.

  2000cites this paper
• NGF administered by microdialysis into rabbit vitreous.

  2000cites this paper
• Neuroprotection: a new treatment modality for glaucoma?

  2000cites this paper
• BDNF attenuates retinal cell death caused by chemically induced hypoxia in rats.

  1999cites this paper
• 'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications.

  1999cites this paper
• Current trends in antiglaucoma therapy

  1999cites this paper
• Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.

  1999cites this paper
• Ganglion cell death in glaucoma: what do we really know?

  1999cites this paper
• Introductory comments on neuroprotection.

  1999cites this paper
• Comparative optic nerve physiology: implications for glaucoma, neuroprotection, and neuroregeneration.

  1999cites this paper